Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Immune cells in cancer, and Genetic factors in colorectal cancer.
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers
Re: Creta, M., Shariat, S.F., Marra, G. et al. Local salvage therapies in patients with radio-recurrent prostate cancer following external beam radiotherapy: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis (2024)
Crowd-sourced benchmarking of single-sample tumor subclonal reconstruction
Predicting Survival with Brain Metastases in the Stereotactic Radiosurgery Era: are Existing Prognostic Scores Still Relevant? Or Can we do Better?
Recurrent FOSL1 rearrangements in desmoplastic fibroblastoma.
Author Correction: The evolutionary history of 2,658 cancers
Author Correction: Inferring structural variant cancer cell fraction
Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
The evolutionary history of 2,658 cancers
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Inferring structural variant cancer cell fraction
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
Drivers underpinning the malignant transformation of giant cell tumour of bone
Drivers underpinning the malignant transformation of giant cell tumour of bone.
Drivers underpinning the malignant transformation of giant cell tumour of bone
Characterizing Genetic Intra-Tumor Heterogeneity Across 2,658 Human Cancer Genomes
Drivers underpinning the malignant transformation of giant cell tumour of bone
Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways
Recurrent rearrangements of FOS and FOSB define osteoblastoma
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
Anti-Folate Receptor Alpha–Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer
Portraits of genetic intra-tumour heterogeneity and subclonal selection across cancer types
2018cited by 44position: middle
Abstract 3000: Pervasive intra-tumour heterogeneity and subclonal selection across cancer types
Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 Signaling
Targeting folate receptor alpha for cancer treatment
Evaluating biomarkers in melanoma